International Biotechnology

Overview Performance Charges & gearing Portfolio Management Structure

Data as at: 25/01/2021

Website Company website
Objective
To achieve capital growth through investing in high growth, development stage biotechnology companies.
Management group
SV Health Managers
AIC sector
Biotechnology & Healthcare
Launch date
06/05/1994
Financial year end
August
Domicile
United Kingdom

Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.

Total assets (m) Price (last close) Price (bid) Price (offer) NAV Dividend dates Discount / premium (%) Gearing (%) 5yr dividend growth (%) p.a. Dividend yield (%)
339.21 835.00 832.00 838.00 841.34 Jul, Dec -0.8 2 N/A 3.4

Dividends

Dividends displayed in traded currency.

Ex-Dividend date Dividend amount Dividend type Special dividend Financial year
24/12/2020 14.200 Capital No 2021
16/07/2020 12.400 Capital No 2020

View dividend history

Dividend cover (years) Revenue reserves (m)
N/A -40.98

Trading information

ISIN TIDM Traded currency
GB0004559349 IBT GBX

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 56,894 1,785,907 22,326,336 76,210,672
Average N/A 92,510 88,122 59,790

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.48 14.77 160.92 474.85
Average N/A 0.76 0.64 0.37

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.